Inactive Instrument

News Lexington BioSciences Inc Canadian Securities Exchange

Equities

CA5290201097

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Registered Plan Private Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Registered Plan Private Investments Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-09-04	CI
Registered Plan Private Investments Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30	CI
Registered Plan Private Investments Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-02	CI
Registered Plan Private Investments Inc. Auditor Raises 'Going Concern' Doubt	23-05-01	CI
Registered Plan Private Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-29	CI
Registered Plan Private Investments Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-30	CI
Registered Plan Private Investments Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-29	CI
Registered Plan Private Investments Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-02	CI
Registered Plan Private Investments Inc. Auditor Raises 'Going Concern' Doubt	22-05-01	CI
Registered Plan Private Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-28	CI
Registered Plan Private Investments Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-30	CI
Registered Plan Private Investments Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-31	CI
Lexington Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
Lexington Biosciences, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-29	CI
Lexington Biosciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-31	CI
Lexington Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-01	CI
Lexington Biosciences, Inc. Approves the Election of Tamara Manuel as Director	20-04-27	CI
Lexington Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-21	CI
Lexington Biosciences, Inc. Announces Executive Changes	20-04-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Lexington BioSciences Inc Canadian Securities Exchange

Equities

CA5290201097

Summary

Filters